Earum Pharmaceuticals Ltd has rescheduled their Board Meeting to discuss various proposals including buyback of equity shares, declaration of final dividend, issue of bonus equity shares, sub-division of equity shares, and finalize the date for the Annual General Meeting of shareholders for the FY 2022-23.